# Assessment of Brain Cognitive Impairment in Breast Cancer

> **NCT05305092** · — · RECRUITING · sponsor: **Tang-Du Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Breast Cancer
- Chemo-brain
- Endocrine Therapy

## Interventions

- **DEVICE:** PET/MRI, psychobehavioral tests and questionnaires, serum biomarkers and stool sample

## Key facts

- **NCT ID:** NCT05305092
- **Lead sponsor:** Tang-Du Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-31
- **Primary completion:** 2027-05-30
- **Final completion:** 2027-05-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2022-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05305092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05305092, "Assessment of Brain Cognitive Impairment in Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05305092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*